Direct Biologics, LLC — Form D

Direct Biologics, LLC of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-13. $11.6M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-12-13
• Form: D
• Accession: 0001953704-22-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $11.6M
• Investors: 116
• Date of first sale: 2022-10-07
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-467216

Issuer

• Name: Direct Biologics, LLC
• CIK: 0001953704
• Entity type: Limited Liability Company
• Jurisdiction: WYOMING
• Address: 5301 SOUTHWEST PARKWAY, SUITE 415, AUSTIN, TX, 78735
• Phone: 800-791-1021

Officers, directors & promoters (11)

More

• CIK 1953704 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search